Zur Hauptnavigation wechseln Zur Suche wechseln Zum Hauptinhalt wechseln

Resurgence of common respiratory viruses in patients with community-acquired pneumonia (CAP)—A prospective multicenter study

  • Members of the CAPNETZ study group
  • Albert-Ludwigs-Universität Freiburg
  • Charite - Universitatsmedizin Berlin
  • Universität Ulm
  • CAPNETZ STIFTUNG
  • German Center for Lung Research (DZL)
  • Technische Universität München
  • Johann Wolfgang Goethe-Universität
  • German Center for Lung Research (DZL)
  • University Hospital Augsburg
  • Carl-Thiem-Clinic Cottbus
  • Medical Clinic
  • Universitätsklinikum Carl Gustav Carus
  • Medizinische Hochschule Hannover
  • Siloah Hospital
  • CAPNETZ Office

Abstract

Background: Community-acquired pneumonia (CAP) is a major global cause of death and hospitalization. Bacteria or community-acquired viruses (CARVs) cause CAP. COVID-19 associated restrictions effectively reduced the circulation of CARVs. Objectives: The aim of this study was to analyze the proportion of CARVs in adult patients with CAP from mid-2020 to mid-2023. Specifically, we aimed to compare the rate of influenza virus, SARS-CoV-2, and RSV detections in patients aged 18–59 years and ≥60 years. Study design: We analyze the proportion of 21 community-acquired respiratory viruses (CARVs) and three atypical bacteria (Bordetella pertussis, Legionella pneumophila, and Mycoplasma pneumoniae) in nasopharyngeal swab samples using molecular multiplex methods within the prospective, multicentre, multinational study of the German study Group CAPNETZ. We used stringent inclusion criteria throughout the study. Results: We identified CARVs in 364/1,388 (26.2 %) patients. In detail, we detected SARS-CoV-2 in 210/1,388 (15.1 %), rhino-/enterovirus in 64/1,388 (4.6 %), influenza virus in 23/1,388 (1.6 %) and RSV in 17/1,388 (1.2 %) of all patients. We detected RSV and influenza more frequently in patients ≥60 years, especially in 22/23 compared to the previous season. None of the atypical bacteria were detected. Conclusions: Beginning in 2023, we demonstrate a re-emergence of CARVs in CAP patients. Effective vaccines or specific antiviral therapies for more than two thirds of the detected viral infections are currently available. High detection rates of vaccine-preventable viruses in older age groups support targeted vaccination campaigns.

OriginalspracheEnglisch
Aufsatznummer105694
ZeitschriftJournal of Clinical Virology
Jahrgang173
ISSN1386-6532
DOIs
PublikationsstatusVeröffentlicht - 08.2024

UN SDGs

Dieser Output leistet einen Beitrag zu folgendem(n) Ziel(en) für nachhaltige Entwicklung

  1. SDG 3 – Gesundheit und Wohlergehen
    SDG 3 – Gesundheit und Wohlergehen

Strategische Forschungsbereiche und Zentren

  • Forschungsschwerpunkt: Infektion und Entzündung - Zentrum für Infektions- und Entzündungsforschung Lübeck (ZIEL)

DFG-Fachsystematik

  • 2.21-03 Medizinische Mikrobiologie und Mykologie, Hygiene, Molekulare Infektionsbiologie
  • 2.21-05 Immunologie
  • 2.22-31 Klinische Infektiologie und Tropenmedizin

Fingerprint

Untersuchen Sie die Forschungsthemen von „Resurgence of common respiratory viruses in patients with community-acquired pneumonia (CAP)—A prospective multicenter study“. Zusammen bilden sie einen einzigartigen Fingerprint.

Dieses zitieren